These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 28483453
1. Bivalent O-glycoside mimetics with S/disulfide/Se substitutions and aromatic core: Synthesis, molecular modeling and inhibitory activity on biomedically relevant lectins in assays of increasing physiological relevance. Kaltner H, Szabó T, Fehér K, André S, Balla S, Manning JC, Szilágyi L, Gabius HJ. Bioorg Med Chem; 2017 Jun 15; 25(12):3158-3170. PubMed ID: 28483453 [Abstract] [Full Text] [Related]
4. Calix[n]arene-based glycoclusters: bioactivity of thiourea-linked galactose/lactose moieties as inhibitors of binding of medically relevant lectins to a glycoprotein and cell-surface glycoconjugates and selectivity among human adhesion/growth-regulatory galectins. André S, Sansone F, Kaltner H, Casnati A, Kopitz J, Gabius HJ, Ungaro R. Chembiochem; 2008 Jul 02; 9(10):1649-61. PubMed ID: 18509838 [Abstract] [Full Text] [Related]
6. Merging carbohydrate chemistry with lectin histochemistry to study inhibition of lectin binding by glycoclusters in the natural tissue context. André S, Kaltner H, Kayser K, Murphy PV, Gabius HJ. Histochem Cell Biol; 2016 Feb 02; 145(2):185-99. PubMed ID: 26553286 [Abstract] [Full Text] [Related]
8. First demonstration of differential inhibition of lectin binding by synthetic tri- and tetravalent glycoclusters from cross-coupling of rigidified 2-propynyl lactoside. André S, Liu B, Gabius HJ, Roy R. Org Biomol Chem; 2003 Nov 21; 1(22):3909-16. PubMed ID: 14664382 [Abstract] [Full Text] [Related]
9. Teaming up synthetic chemistry and histochemistry for activity screening in galectin-directed inhibitor design. Roy R, Cao Y, Kaltner H, Kottari N, Shiao TC, Belkhadem K, André S, Manning JC, Murphy PV, Gabius HJ. Histochem Cell Biol; 2017 Feb 21; 147(2):285-301. PubMed ID: 28013366 [Abstract] [Full Text] [Related]
13. Inhibitory potential of chemical substitutions at bioinspired sites of β-D-galactopyranose on neoglycoprotein/cell surface binding of two classes of medically relevant lectins. Giguère D, André S, Bonin MA, Bellefleur MA, Provencal A, Cloutier P, Pucci B, Roy R, Gabius HJ. Bioorg Med Chem; 2011 May 15; 19(10):3280-7. PubMed ID: 21524586 [Abstract] [Full Text] [Related]
18. Glycocluster design for improved avidity and selectivity in blocking human lectin/plant toxin binding to glycoproteins and cells. André S, Lahmann M, Gabius HJ, Oscarson S. Mol Pharm; 2010 Dec 06; 7(6):2270-9. PubMed ID: 21028902 [Abstract] [Full Text] [Related]
19. Studies on Unprocessed and Acid-Treated Arabinogalactan from Larch as an Inhibitor of Glycan Binding of a Plant Toxin and Biomedically Relevant Human Lectins. André S, Classen B, Gabius HJ. Planta Med; 2015 Aug 06; 81(12-13):1146-53. PubMed ID: 26039261 [Abstract] [Full Text] [Related]
20. Selenoglycosides in silico: ab initio-derived reparameterization of MM4, conformational analysis using histo-blood group ABH antigens and lectin docking as indication for potential of bioactivity. Strino F, Lii JH, Koppisetty CA, Nyholm PG, Gabius HJ. J Comput Aided Mol Des; 2010 Dec 06; 24(12):1009-21. PubMed ID: 20976527 [Abstract] [Full Text] [Related] Page: [Next] [New Search]